Back
SoftBank Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
50
SFTBY
SoftBank Group
Last Price:
$26.00
Seasonality Move:
8.91%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$48.31
Seasonality Move:
19.25%
Sell
50
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
-
The current SoftBank Group [SFTBY] share price is $26.00. The Score for SFTBY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.35. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $26.00The current trend is relatively stagnant and SFTBY is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SFTBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 51.63 | Buy |
| Chaikin Money Flow: | -311081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.5 - 26.66) | Buy |
| Bollinger Bands (100): | (24.69 - 30.41) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.67 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | 1418157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.41 - 44.63) | Buy |
| Bollinger Bands (100): | (31.68 - 49.74) | Buy |
SFTBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.63 | Sell |
| 20-day SMA: | 26.04 | Sell |
| 50-day SMA: | 25.28 | Buy |
| 200-day SMA: | 28.34 | Sell |
| 8-day EMA: | 26.36 | Sell |
| 20-day EMA: | 25.96 | Buy |
| 50-day EMA: | 26.02 | Sell |
| 200-day EMA: | 27.59 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.54 | Buy |
| 20-day SMA: | 42.36 | Buy |
| 50-day SMA: | 41.34 | Buy |
| 200-day SMA: | 34.7 | Buy |
| 8-day EMA: | 43.02 | Buy |
| 20-day EMA: | 41.92 | Buy |
| 50-day EMA: | 41.49 | Buy |
| 200-day EMA: | 36.34 | Buy |
SoftBank Group Earnings Growth & SFTBY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.69 per share.
SoftBank Group Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||